In this article, we will discuss Belimumab and Postmarketing Experience. So, let’s get started.
Belimumab and Postmarketing Experience
The following adverse reactions have been identified during postapproval use of Belimumab. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.